Autophagy Precedes Apoptosis in Angiotensin II-Induced Podocyte Injury

Abstract

Background/Aims: Angiotensin II (Ang II) induces podocyte injury resulting in apoptosis in vitro and in vivo. However, the relationship between autophagy and apoptosis in Ang II-induced podocyte injury is unknown and the role of Ang II-induced autophagy in podocyte survival or death remains unclear. We investigated the sequential relationship between autophagy and apoptosis in Ang II-induced podocytes as well as the role of phosphatidylinositide 3-kinase (PI3-kinase). Methods: Mouse podocytes were incubated in media containing various concentrations of Ang II and at different incubation times. The changes of podocyte autophagy and apoptosis were observed by electron microscopy, confocal imaging, western blotting, and FACS assay according to the presence of Ang II. Results: Ang II enhanced the podocyte expression of the autophagic proteins, LC3A/B-II and beclin-1, and also increased the number of autophagosomes compared with control cells at early phase of 12 hours in a dose-dependent manner. This effect was inhibited by pretreatment with 3-methyladenine (3-MA), a PI3-kinase class III inhibitor. Thereafter, the Ang II-induced enhancement in autophagy decreased, whereas, podocyte apoptosis appeared later at 24 hours in concentration-and time-dependent manners in FACS and TUNEL assays. 3-MA and LY294002, a pan PI3-kinase inhibitor, further increased Ang II-induced podocyte apoptosis. Suppression of autophagy by Atg5 siRNA could induce podocyte apoptosis and further augment high-dose Ang II-induced podocyte apoptosis. Conclusion: These findings suggest that Ang II promotes autophagy in podocytes before apoptosis as an early adaptive cytoprotective mechanism for podocyte survival after Ang II treatment, and the transitional imbalance between autophagy and apoptosis causes podocyte injury.

Sex Influence on Autophagy Markers and miRNAs in Basal and Angiotensin II-Treated Human Umbilical Vein Endothelial Cells

“…This is in line with the fact that Ang II is a facilitator of the translocation of PARK2 into mitochondria, where it co-localizes into Parkin-positive mitochondria [70], suggesting a potential role for Beclin-1 in linking mitochondria to autophagosomes [71]. Similar results were obtained in rat hearts [72] and in immortalized mouse podocytes of unknown sex [73].…”

Dopamine D1 Receptor in Cancer

“…The modulation of these compounds by the D1 receptor agonist was previously described in tumorous and non-tumorous cells, including neuroblastoma, astrocytes, or macrophages [69][70][71]. D1R activation in triple-negative breast cancer cell line (4T1.2) leads to the induction of apoptosis (increased level of cleaved caspase 3), autophagy (elevation of LC3-phosphatidylethanolamine conjugate-LC3A/B II), and the phosphorylation of eukaryotic translation initiation factor 2-alpha (eIF2a) [55,72,73]. The increase in phospho-eIF2a level may contribute to caspase cleavage and subsequent apoptosis [74].…”

Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus

“…AGEs are involved in activated angiotensin II and trigger mesangial hypertrophy [ 70 ]. Angiotensin II also induces ROS production [ 71 , 72 ].…”